"FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next Month" - Marijuana Moment
"FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next Month" - Marijuana Moment
“美國食品藥品管理局專家委員會將在下個月審查創傷後應激障礙的搖頭丸輔助療法”-大麻時刻
The Food and Drug Administration (FDA) is taking the next step in its historic review of MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), scheduling a meeting next month where an expert committee will examine the evidence behind the application.
美國食品藥品監督管理局（FDA）正在對用於治療創傷後應激障礙（PTSD）的搖頭丸輔助療法進行歷史性審查，並計劃在下個月舉行一次會議，專家委員會將審查該申請背後的證據。
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) announced on Monday that FDA's Psychopharmacologic Drugs Advisory Committee will meet on June 4 to review the results of its clinical trials for the psychedelic-assisted therapy.
Lykos Therapeutics（前身爲MAPS公益公司）週一宣佈，美國食品藥品管理局的精神藥理藥物諮詢委員會將於6月4日舉行會議，審查其迷幻輔助療法的臨床試驗結果。
Not only will this be the first time in 25 years since FDA has reviewed a new PTSD treatment option, it's the...
這不僅是自美國食品藥品管理局審查新的創傷後應...
登入免費觀看全文
登入/註冊